They always brag about JAMA as if that journal turned the tides for this poor company. But if it were really as important as they claim, then why is the MHRA still doing a "thorough" review before making a decision? I know why… it’s probably because that journal is the only reason the regulators are even taking the time to review this ~ otherwise, it would’ve been a straight-up rejection.
Market Data 
Markets 
AI
